Voglio sapere a riguardo di…

Federal Register / Vol. 86, No. 59 / Tuesday, March 30, 2021 / Proposed Rules instantaneously available for public view on Regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.
Paper comments: Paper comments that duplicate electronic submissions are not necessary. Should you wish to mail a paper comment, in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attn: DEA
Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
FOR FURTHER INFORMATION CONTACT:
Terrence L. Boos, Drug and Chemical Evaluation, Diversion Control Division, Drug Enforcement Administration;
Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152;
Telephone: 571 3623249.
SUPPLEMENTARY INFORMATION:

jbell on DSKJLSW7X2PROD with PROPOSALS

Posting of Public Comments Please note that all comments received in response to this docket are considered part of the public record.
They will, unless reasonable cause is given, be made available by the Drug Enforcement Administration DEA for public inspection online at http
www.regulations.gov. Such information includes personal identifying information such as your name, address, etc. voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received. If you want to submit personal identifying information such as your name, address, etc. as part of your comment, but do not want it to be made publicly available, you must include the phrase PERSONAL IDENTIFYING
INFORMATION in the first paragraph of your comment. You must also place all of the personal identifying information you do not want made publicly available in the first paragraph of your comment and identify what information you want redacted.
If you want to submit confidential business information as part of your comment, but do not want it to be made publicly available, you must include the phrase CONFIDENTIAL BUSINESS
INFORMATION in the first paragraph of your comment. You must also prominently identify the confidential business information to be redacted within the comment.
Comments containing personal identifying information or confidential business information identified as directed above will be made publicly available in redacted form. If a comment has so much confidential business
VerDate Sep<11>2014

16:16 Mar 29, 2021

Jkt 253001

information that it cannot be effectively redacted, all or part of that comment may not be made publicly available.
Comments posted to http
www.regulations.gov may include any personal identifying information such as name, address, and phone number included in the text of your electronic submission that is not identified as directed above as confidential.
An electronic copy of this proposed rule is available at http
www.regulations.gov for easy reference.
Legal Authority The Controlled Substances Act CSA
gives the Attorney General the authority to specify, by regulation, a chemical as a list I chemical. 21 U.S.C. 80234. The term list I chemical means a chemical that is used in manufacturing a controlled substance in violation of the CSA and is important to the manufacture of the controlled substance. Id. Pursuant to 28 CFR
0.100b, the Attorney General has delegated his authority to designate list I chemicals to the Administrator of DEA
Administrator.
The DEA regulations set forth the process by which DEA may add a chemical as a listed chemical. As set forth in 21 CFR 1310.02c, the agency may do so by publishing a final rule in the Federal Register following a published notice of proposed rulemaking with at least 30 days for public comments. The current list of all list I chemicals is available in 21 CFR
1310.02a.
In addition, the United States is a party to the 1988 United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances 1988 Convention, December 20, 1988, 1582 U.N.T.S. 95.
Under Article 12 of the 1988
Convention, when the United States receives notification that a chemical has been added to Table I or Table II of the 1988 Convention, the United States is required to take measures it deems appropriate to monitor the manufacture and distribution of that chemical within the United States and to prevent its diversion. The 1988 Convention also requires the United States to take other specified measures related to that chemical, including measures related to its international trade.
Background By letter dated May 7, 2020, in accordance with Article 12, paragraph 6
of the 1988 Convention, the SecretaryGeneral of the United Nations informed the United States Government that the chemical methyl alphaphenylacetoacetate MAPA, including
PO 00000

Frm 00012

Fmt 4702

Sfmt 4702

16559

its optical isomers, was added to Table I of the 1988 Convention. This letter was prompted by a March 4, 2020, decision at the 63rd Session of the United Nations Commission on Narcotic Drugs CND to add MAPA to Table I. As discussed above, the United States is a party to the 1988 Convention, and has certain obligations pursuant to Article 12. By designating MAPA as a list I
chemical, the United States will fulfill its obligations under the 1988
Convention.
MAPA is used in, and is important to, the manufacture of the schedule II
substances phenylacetone also known as phenyl-2-propanone, P2P, or benzyl methyl ketone, methamphetamine, and amphetamine. Throughout the 1970s, methamphetamine was illicitly produced in the United States, primarily with the precursor chemical P2P. In response to the illicit use of P2P, DEA
controlled P2P as a schedule II
controlled substance in 1980 pursuant to the immediate precursor provisions of the CSA, specifically 21 U.S.C.
811e.1 Clandestine laboratory operators have circumvented this control by developing a variety of synthetic methods for producing P2P.
Congress and DEA responded by placing controls on precursor chemicals used in the illicit production of P2P, such as phenylacetic acid and its salts and esters, acetic anhydride, benzyl cyanide, benzaldehyde, and nitroethane.2 3 However, clandestine laboratory operators circumvented these controls by using alternative precursors that avoid the production of P2P:
Ephedrine and pseudoephedrine for the production of methamphetamine; and phenylpropanolamine for the production of amphetamine. This led Congress and DEA to place stringent controls on the manufacture, distribution, importation, and exportation of ephedrine its salts, optical isomers, and salts of optical isomers, pseudoephedrine, and phenylpropanolamine controlled as list I chemicals, and pharmaceutical products containing these chemicals through the Combat Methamphetamine Epidemic Act of 2005 Title VII of the USA PATRIOT Act Improvement and Reauthorization Act of 2005, Pub. L.
109117, the Methamphetamine Production Prevention Act of 2008 Pub.
1 44

FR 7182 Feb. 11, 1980.
November 18, 1988, the Chemical Diversion and Trafficking Act Subtitle A of Title VI of Pub.
L. 100690 was enacted.
3 Under 21 CFR 1310.02a, benzaldehyde, benzyl cyanide, nitroethane, and phenylacetic acid including its salts and esters are list I chemicals.
Under 21 CFR 1310.02b, acetic anhydride is a list II chemical.
2 On
E:FRFM30MRP1.SGM

30MRP1